v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04331054 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : May 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
camille.taille@aphp.fr |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-04-02 |
Recruitment status
Last imported at : Aug. 4, 2021, 2 p.m. Source : ClinicalTrials.gov |
Terminated |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
inclusion criera : - patient ≥ 18 years old and ≤ 75 years old - laboratory proved infection by covid-19 by rt-pcr on a respiratory biological sample within 2 days - hospitalization is required according to current local recommendations - patient affiliated to a social security regime - patient able to give free, informed and written consent exclusion criteria : - oxygen flow rate >8l/min at inclusion - current treatment with any inhaled steroid (any other form of steroid administration does not exclude the patient) - intensive care unit is required for the patient (based on investigator judgement) - patient with cognitive impairment which do not guarantee proper use of the treatment by the patient himself - pregnant (positive β-hcg at inclusion) or breastfeeding women - participation in another interventional drug study involving human participants and concerning covid-19 infection or being in the exclusion period of a previous study involving human participants - contraindications to the treatments (history of hypersensitivity) - patient admitted for isolation, for social reason or due to comorbidities without gravity sign - long-term patient treated with digitalis, disopyramide, procainamide or phenothiazine that could lengthen the qt space |
Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Assistance Publique - Hôpitaux de Paris |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
75 |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
France |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Moderate/severe/critical disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
5: Moderate/severe/critical disease at enrollment |
Total sample size
Last imported at : Aug. 4, 2021, 2 p.m. Source : ClinicalTrials.gov |
146 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Time (in days) to clinical improvement within 30 days after randomization |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1435, "treatment_name": "Budesonide+formoterol", "treatment_type": "Corticosteroids+respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |